EpicentRx
Latest round
- Series B
Last raised
- Mar 2008
Total raised
- $2.3M
Investors
- 1
About EpicentRx
, operates as a clinical-stage immuno-oncology platform that develops anticancer compounds for immunotherapy of cancer patients and chemo/radioprotection of normal tissues. The company advances a smart virus program that eliminates tumors and prevents them from returning.
Who invested in EpicentRx
1 investor across 1 round
See all investors in EpicentRx
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Mar 27, 2008
Amount
$2.3M
Investors
Questions about EpicentRx
Who invested in EpicentRx?
EpicentRx has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has EpicentRx raised?
EpicentRx has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did EpicentRx last raise money?
EpicentRx's most recent round on record is a Series B, in Mar 2008.
What does EpicentRx do?
, operates as a clinical-stage immuno-oncology platform that develops anticancer compounds for immunotherapy of cancer patients and chemo/radioprotection of normal tissues.
Where is EpicentRx headquartered?
EpicentRx is headquartered in San Diego, US.
Which VCs invest in companies like EpicentRx?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at EpicentRx's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like EpicentRx? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.